John Sargent

BroadReach Healthcare

BroadReach is radically focused on improving healthcare access, patient outcomes and continuing wellness for underserved populations around the globe.

Focus: Finance
Geographic Area of Impact: South Africa, Botswana, 20 other countries in Africa, and strategic countries in Asia and Latin America
Model: Social Business
Number of Direct Beneficiaries: HIV treatment support for over 500,000 patients
Annual Budget: USD $27 million (2014)
Percentage Earned Revenue: 11% (2014)

The Social Problem
There are a number of challenges and roadblocks across the entire healthcare value chain in developing markets, spanning drug manufacturing to importation and registration, to delivery of healthcare services and products at the point of care. The key bottlenecks include a lack of infrastructure and financial resources, limited human resources, lack of training and skillsets, as well as limited information and data to understand healthcare performance and to assist stakeholders. Although billions of dollars have been invested through donor programs and much has been accomplished, there are many areas where improvements can be made.

Innovation and Activities
BroadReach is a patient-centred healthcare solutions company empowering local providers and global leaders inside governments, donor organizations, NGOs and commercial healthcare companies to efficiently deliver improved patient access, outcomes, and social well-being to under-served populations. It does this through its unique data analytics and social collaboration platform combined with proven strategic and operational know-how and on-the-ground staff to provide and implement actionable insights.

BroadReach has used its approach to shape healthcare policies in Botswana, South Africa and at the international level, and assisted some of the world’s largest pharmaceutical companies in designing strategies and business plans to create commercial access models to provide healthcare to those at the base of the pyramid.

BroadReach has also utilized this approach to conduct health systems improvement projects across 1,000 health facilities, train over 10,000 healthcare providers and 1,500 healthcare leaders and managers, and educate over 5 million patients.

BroadReach has worked on developing some of Africa’s most ground-breaking, innovative and successful healthcare programs, including Africa’s first national HIV treatment program, which has already provided HIV treatment support for over 500,000 patients, as well as HIV care support for over 1 million patients.

The Entrepreneur
Dr. John Sargent is an internationally recognized thought-leader who brings extensive experience in market development strategy, health systems strengthening, large-scale patient education programmes, and creation and implementation of public-private partnerships in emerging markets. Prior to co-founding BroadReach, John gained experience as a strategic and operational consultant with expertise spanning multiple disease areas across public and private-health sectors. He earned his undergraduate degree from Dartmouth College, a Master's degree from Oxford University as a Fulbright Scholar, and his Doctor of Medicine degree from Harvard Medical School. He is a member of the Board of Directors of the Fulbright Association and was nominated in the Devex Top 40 Under 40 Leaders in Development 2010/11.

Dr. Ernest Darkoh is an internationally recognized expert in HIV/AIDS programme management, strategic planning, systems development and large-scale healthcare programme implementation. His expertise and input are frequently sought by international organizations including the World Bank, WHO, UNICEF and many multinational Fortune 500 companies. Ernest was named one of 18 “Global Health Heroes” by Time Magazine, and featured in the highly acclaimed PBS documentary “Rx for Survival”. He has been elected as a Young Global Leader by the World Economic Forum. He received his MD from Harvard Medical School and his MPH from Harvard School of Public Health. He completed his MBA at the Said School of Business at Oxford University as a Fulbright Scholar.